Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo (13)C magnetic resonance spectroscopy study.
about
The Contribution of Blood Lactate to Brain Energy Metabolism in Humans Measured by Dynamic 13C Nuclear Magnetic Resonance SpectroscopyAltered brain mitochondrial metabolism in healthy aging as assessed by in vivo magnetic resonance spectroscopyEffects of age and sex on brain glutamate and other metabolitesMetabolic Alterations Associated to Brain Dysfunction in DiabetesMagnetic resonance spectroscopy studies of human metabolism.Glutamate and glutamine: a review of in vivo MRS in the human brainNeuroimaging in repetitive brain trauma.What have novel imaging techniques revealed about metabolism in the aging brain?Spectral improvement by fourier thresholding of in vivo dynamic spectroscopy dataN-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.Ornithine transcarbamylase deficiency with persistent abnormality in cerebral glutamate metabolism in adults.Neuronal and astrocytic metabolism in a transgenic rat model of Alzheimer's disease.Sodium MR imaging detection of mild Alzheimer disease: preliminary study13C MRS studies of neuroenergetics and neurotransmitter cycling in humansGlial dysfunction in abstinent methamphetamine abusers.Glutamine acts as a neuroprotectant against DNA damage, beta-amyloid and H2O2-induced stress.Metabolic imaging of mild traumatic brain injury.Swift Acetate Glial Assay (SAGA): an accelerated human ¹³C MRS brain exam for clinical diagnostic use.Hypermetabolic state in the 7-month-old triple transgenic mouse model of Alzheimer's disease and the effect of lipoic acid: a 13C-NMR study.13C MRS of occipital and frontal lobes at 3 T using a volume coil for stochastic proton decoupling.In vivo 13C magnetic resonance spectroscopy of human brain on a clinical 3 T scanner using [2-13C]glucose infusion and low-power stochastic decoupling.Reduced hippocampal N-acetyl-aspartate (NAA) as a biomarker for overweight.Reversal of metabolic deficits by lipoic acid in a triple transgenic mouse model of Alzheimer's disease: a 13C NMR study.Regional proton magnetic resonance spectroscopy patterns in dementia with Lewy bodies.Effects of ketone bodies in Alzheimer's disease in relation to neural hypometabolism, β-amyloid toxicity, and astrocyte function.Minimally invasive biomarker confirms glial activation present in Alzheimer's disease: a preliminary study.Mitochondrial function in ageing: coordination with signalling and transcriptional pathways.Energy metabolism and inflammation in brain aging and Alzheimer's disease.Imaging and spectroscopic approaches to probe brain energy metabolism dysregulation in neurodegenerative diseases.Metabolomic-guided discovery of Alzheimer's disease biomarkers from body fluid.Effect of memantine on resting state default mode network activity in Alzheimer's disease.Novel Biomarkers of Human GM1 Gangliosidosis Reflect the Clinical Efficacy of Gene Therapy in a Feline Model.3T hippocampal glutamate-glutamine complex reflects verbal memory decline in aging.Improved resolution of glutamate, glutamine and γ-aminobutyric acid with optimized point-resolved spectroscopy sequence timings for their simultaneous quantification at 9.4 T.Alterations in Cerebral Cortical Glucose and Glutamine Metabolism Precedes Amyloid Plaques in the APPswe/PSEN1dE9 Mouse Model of Alzheimer's Disease.Effects of age and sex on the concentrations of glutamate and glutamine in the human brain.Alteration of interaction between astrocytes and neurons in different stages of diabetes: a nuclear magnetic resonance study using [1-(13)C]glucose and [2-(13)C]acetate.Using direct infusion mass spectrometry for serum metabolomics in Alzheimer's disease.Lavandula angustifolia Effects on Rat Models of Alzheimer's Disease Through the Investigation of Serum Metabolic Features Using NMR Metabolomics.
P2860
Q22336991-6395C7BC-DE81-47C4-817A-C447911F6C0EQ24596354-B0F5238C-8EDC-443B-B202-93DBA1D5BDA5Q24607825-CFA703AA-C7ED-42BE-AD6F-710DE6E6A5D3Q26783376-78ED67AE-F15E-485D-AE01-620CCD0187F0Q30467992-8794A8F4-E76C-4501-87D3-89CC29299AC9Q30677120-F0508598-28A6-4F29-91D8-96C0C2FCD6A6Q30836857-82E36D1B-DC02-49FB-84AE-13DE31417ACCQ30850844-91B23925-E1DE-4E6F-BDFA-66392EBCD776Q31002574-28EE2975-A94E-4880-93F6-2EB655CFCC39Q33271816-9A761B6C-CB3C-4C32-B14B-EB67657C2E10Q33476720-72415602-8A43-4B61-AD55-00B164460371Q33581218-7F05FEAE-F1DA-4F1C-A086-9A140279C20EQ33836441-20EE766A-5CD3-4A26-8C70-BAE5DACEC69CQ34007144-355335FC-4042-42CD-B640-0D73C8E4B60AQ34171050-049DAFF5-06AA-409D-A79F-F379AFF4E4B9Q34193698-4780A1C3-39BB-4306-970F-471C27BE0D57Q34299002-D67FA4E4-578C-4C1A-8412-F70BA82D053FQ34361280-69452180-C9D0-4E57-8FFC-184F1A945997Q34727429-8BDC16E0-B7DB-4FC5-8745-9A32F970DCA2Q35176020-AAB4A271-D92E-49BB-AD68-AF6FE4AD2712Q37363007-BD2EE970-2369-4D0C-A0C2-0935DB31F85AQ37554870-6E2393AE-2987-4B32-AB63-0ECD6AE6FD8DQ37559324-B112A18F-A0EE-490C-A24B-94D16AC29943Q37652823-C7471F9C-170B-444B-A94E-B2FFF9C1F2EEQ38400509-D3D38BF1-470D-4A3D-A315-8228C5C5802EQ38416641-1675457E-9541-4BDC-AA16-66ED0C0893F8Q38570535-A9A4E9A9-E40A-4549-B515-C781BFB96BECQ38828060-FA8A722D-3996-4FB0-BD4F-D33FCD4DA886Q38918493-9D74CFE9-BD36-49F6-844D-875F49226A4DQ39181900-21425D01-D919-4454-896C-1139B3FCD8ABQ39791889-0D231A30-D569-4136-B269-FA49ED565E2AQ40319080-85D46F9A-95A6-4F2A-A678-2B2404E0BC6DQ46921307-F6857282-4585-4461-99E1-9AD21408D49AQ47985831-1A9758B2-A5C6-417C-B66D-CE3DCF0166D2Q48054389-59C51822-2A28-49D9-9387-8AA444E0B7FEQ48092892-171285D3-F72D-48B9-83A5-057AB7E85B93Q48645242-635DDB8E-ACD6-4ED1-825A-BE91FA475178Q53356993-EECBB7D9-54B7-453E-8FFC-C83D21DA6FE7Q55279842-01FB87CB-47D8-446D-B8A2-2EEE8956BFA6
P2860
Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo (13)C magnetic resonance spectroscopy study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Reduced glutamate neurotransmi ...... resonance spectroscopy study.
@en
Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo
@nl
type
label
Reduced glutamate neurotransmi ...... resonance spectroscopy study.
@en
Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo
@nl
prefLabel
Reduced glutamate neurotransmi ...... resonance spectroscopy study.
@en
Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo
@nl
P2093
P1476
Reduced glutamate neurotransmi ...... c resonance spectroscopy study
@en
P2093
Alexander P Lin
Brian D Ross
Cathleen Enriquez
P2888
P356
10.1007/S10334-003-0004-X
P577
2003-02-01T00:00:00Z